Bempedoic Acid Reduces Major Adverse Cardiovascular Events for Statin-Intolerant Patients

J Gen Intern Med. 2024 Jun;39(8):1536-1538. doi: 10.1007/s11606-024-08704-y.

Authors

John M Cunningham¹, Mehrshid Kiazand²

Affiliations

¹ Division of Hospital Medicine, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health at San Antonio, San Antonio, TX, USA. [email protected].
² Department of Medicine, University of Pittsburg Medical Center Mercy HospitalSchool of Medicine, Pittsburgh, PA, USA.

PMID: 38575847
PMCID: PMC11169385 (available on 2025-06-01)
DOI: 10.1007/s11606-024-08704-y

No abstract available

MeSH terms

Aged
Cardiovascular Diseases* / prevention & control
Dicarboxylic Acids* / adverse effects
Dicarboxylic Acids* / therapeutic use
Fatty Acids* / adverse effects
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Male
Middle Aged

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
Fatty Acids
Dicarboxylic Acids